Merit Medical Systems projects non-GAAP EPS of $4.25-$4.35 for 2026 and boosts organic growth outlook to 6.9%-7.5%.
Merit Medical Systems updated its 2026 non-GAAP earnings per share guidance to a range of $4.25 to $4.35, while raising its organic growth outlook to 6.9%-7.5%. The company cited strong performance in its latest quarterly results.
In Q2 2026, Merit Medical reported total revenue of $418.8 million, reflecting a 10% year-over-year increase on a GAAP basis and 9% growth on a constant currency basis. The revised guidance follows a period of consistent revenue expansion.
The company did not disclose immediate market reactions to the updated projections.